McKesson Reports Q1 2027 Sales and Profit Growth Amid Outlook Raise

SentiSense · Published · Updated

McKesson's first-quarter 2027 sales rose 8%, driven by strong growth in its specialty drug business. The company lifted its full-year earnings per sha...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis